A putative class action has been lodged in New Jersey against the maker of the cholesterol-reducing drug Atorvastatin, which was found to be tainted with glass particles. The suit was filed the day after Ranbaxy Pharmaceuticals announced that it had recalled several lots of the drug and the day before the Food and Drug Administration issued a public advisory.
Source: http://www.law.com/jsp/law/sign_me_in.jsp?article=http://www.law.com/jsp/nj/PubArticleNJ.jsp?id=1202580149574&rss=newswire
local lawyer local solicitors mold attorney need a lawyer patent lawyer
No comments:
Post a Comment